2025
2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis
Sammaritano L, Askanase A, Bermas B, Dall'Era M, Duarte‐García A, Hiraki L, Rovin B, Son M, Alvarado A, Aranow C, Barnado A, Broder A, Brunner H, Chowdhary V, Contreras G, Felix C, Ferucci E, Gibson K, Hersh A, Izmirly P, Kalunian K, Kamen D, Rollins B, Smith B, Thomas A, Timlin H, Wallace D, Ward M, Azzam M, Bartels C, Cunha J, DeQuattro K, Fava A, Figueroa‐Parra G, Garg S, Greco J, Cuéllar‐Gutiérrez M, Iyer P, Johannemann A, Jorge A, Kasturi S, Kawtharany H, Khawandi J, Kirou K, Legge A, Liang K, Lockwood M, Sanchez‐Rodriguez A, Turgunbaev M, Williams J, Turner A, Mustafa R. 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis & Rheumatology 2025 PMID: 40331662, DOI: 10.1002/art.43212.Peer-Reviewed Original ResearchManagement of lupus nephritisLupus nephritisAmerican College of Rheumatology (ACRTreatment decisionsLupus nephritis therapyBest practice statementsQuality of evidencePulse glucocorticoidsGlucocorticoid taperingImmunosuppressive agentsRenal responseRecommendations AssessmentNephritisAmerican CollegeVoting panelClinical situationsGRADE recommendationsIndividual patientsTherapyPractice statementsEvidence-basedPICO questionClinical questionsPICO formatSystematic literature review
2006
Association of increased interferon‐inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus
Feng X, Wu H, Grossman J, Hanvivadhanakul P, FitzGerald J, Park G, Dong X, Chen W, Kim M, Weng H, Furst D, Gorn A, McMahon M, Taylor M, Brahn E, Hahn B, Tsao B. Association of increased interferon‐inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis & Rheumatism 2006, 54: 2951-2962. PMID: 16947629, DOI: 10.1002/art.22044.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosus patientsSystemic lupus erythematosusActive renal diseaseLupus nephritis patientsIFN scoreDisease activityLupus erythematosusNephritis patientsLupus nephritisPresence of anti-double-stranded DNARenal diseaseNormal controlsPhysician Global Assessment scoreAnti-dsDNA antibody positivityAnti-double-stranded DNAHigher IFN scoresInactive lupus nephritisSafety of EstrogensGlobal assessment scoreAssociated with neurological manifestationsAssociated with proteinuriaLupus nephritis therapyPeripheral blood cellsRheumatic disease controlsExpression levels
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply